214 chapter 2 Table 50. Baseline characteristics of included studies investigating ultrasonography reference country study design ntot ni femalei mean agei, y sizei, mm Raber 2000 Austria PS 120 120 86% 50 50 (17-84) Alexander 2004 USA RS 993 115 n.s. n.s. n.s. De Nicola 2005 Brazil RS 86 86 n.s. n.s. n.s. Moon 2007 South Korea PS 153 33 n.s. n.s. n.s. Sebastianes 2007 Brazil PS 42 42 90% 45 45 ± 16 Sippel 2007 USA RS 325 295 82% 47 47 (12-85) Gulcelik 2008 Turkey PS 98 98 84% 47 47 ± 13 Hales 2008 USA PS 15 14 93% 48 48 ± 15 Chin 2010 Canada RS 665 211 84% n.s. benign 50 / malignant 44 Rago 2010 Italy RS 176 142 n.s. n.s. n.s. Rosario 2010 Brazil n.s. 102 102 78% 50 50 (12-85) Yoon 2010 South Korea RS 99 99 87% n.s. benign 42 ± 14 / malignant 50 ± 20 Dutta 2011 UK RS 59 59 85% n.s. benign 50 (18-77) / malignant 38 (22-68) Kim 2011 South Korea PS 51 51 n.s. n.s. n.s. Lee 2011 South Korea RS 819 40 n.s. n.s. benign 26 (12-70) / malignant 6 Lippolis 2011 Italy PS 102 102 68% n.s. median 47 (19-73) Maia 2011 Brazil RS 80 80 88% n.s. benign 50 ± 13 / malignant 48 ± 11 Turanli 2011 Turkey RS 70 70 90% n.s. benign 45 ±1.5 / malignant 43 ±3.1 Cantisani 2012 Italy PS 140 140 91% n.s. median 38 (17-78) Deandreis 2012 France PS 56 56 76% n.s. median 21 (10-57) Carr 2013 USA RS 140 140 80% n.s. n.s. Gweon 2013 South Korea RS 155 155 86% 48 48 (22-79) Jeong 2013 South Korea RS 165 165 90% 49 49 (22-76) Lee, KH 2013 South Korea RS 75 75 73% 52 benign 52 ± 11 / malignant 52 ± 15 Lee, SH 2013 South Korea RS 97 97 88% 49 49 Mohey 2013 Egypt PS 46 16 n.s. n.s. n.s. Parikh 2013 USA RS 84 84 77% n.s. benign 50±16 / malignant 53±17 Pompili 2013 Italy RS 102 102 78% 46 suspicious TN 29 ± 12 Russ 2013 France PS 263 98 n.s. n.s. n.s. Batawil 2014 Saudi Arabia RS 78 78 90% 44 44 ± 14 Cakir 2014 Turkey PS 270 270 95% 48 48 ± 11 Calo 2014 Italy RS 249 249 80% 52 52 ± 14 Chng 2014 UK RS 144 144 76% n.s. benign 44 ± 15 / malignant 50 ± 16
RkJQdWJsaXNoZXIy MTk4NDMw